Full Project List

Since our inception as an outcome committee in 2015, we have consistently and considerably expanded our ability to produce rigorous outcomes research. In 2018, we established a more formal program and leadership, including full time outcomes research staff. The result of these allocated resources has been a productive output across multiple specialty disease states. Below are highlighted outcomes from studies completed in recent years.

Manuscripts Published:

Shah, N., Mitchell, R., Proctor, S.T., Choi, L., DeClercq, J., Jolly, J… & Zuckerman, A.D. (2019). High Rates of Medication Adherence in Patients with Pulmonary Arterial Hypertension: An Integrated Specialty Pharmacy Approach. PLoS One.

Shah N, Jolly J, Horst S, Peter M, Limper H, Zuckerman AD. Development of a Quality Measures Tool for the Use of Self-injectable Biologic Therapy in Inflammatory Bowel Disease: An Integrated Specialty Pharmacy Initiative. American Journal of Health-System Pharmacy.

Cornell, R. F., Goldhaber, S. Z., Engelhardt, B. G., Moslehi, J., Jagasia, M., Patton, D., ... & Piazza, G. (2019). Apixaban for Primary Prevention of Venous Thromboembolism in Patients with Multiple Myeloma Receiving Immunomodulatory Therapy. Frontiers in oncology, 9.

Banks, A. M., Peter, M. E., Holder, G. M., Jolly, J. A., Markley, B. M., Zuckerman, S. L., ... & Zuckerman, A. D. (2019). Adherence to Disease-Modifying Therapies at a Multiple Sclerosis Clinic: The Role of the Specialty Pharmacist. Journal of pharmacy practice, 0897190018824821.

Reynolds, V. W., Chinn, M. E., Jolly, J. A., Kelley, T. N., Peter, M. E., Choi, L., ... & Zuckerman, A. D. (2019). Integrated specialty pharmacy yields high PCSK9 inhibitor access and initiation rates. Journal of clinical lipidology.

Zuckerman, A., Carver, A., & Chastain, C. A. (2018). Building a Hepatitis C Clinical Program: Strategies to Optimize Outcomes. Current treatment options in infectious diseases, 10(4), 431-446.

Schlendorf, K. H., Zalawadiya, S., Shah, A. S., Wigger, M., Chung, C. Y., Smith, S., ... & Sacks, S. B. (2018). Early outcomes using hepatitis C–positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies. The Journal of Heart and Lung Transplantation, 37(6), 763-769.

Zuckerman, A., Douglas, A., Nwosu, S., Choi, L., & Chastain, C. (2018). Increasing success and evolving barriers in the hepatitis C cascade of care during the direct acting antiviral era. PloS one, 13(6), e0199174.

Bagwell, A., Kelley, T., Carver, A., Lee, J. B., & Newman, B. (2017). Advancing patient care through specialty pharmacy services in an academic health system. Journal of managed care & specialty pharmacy, 23(8), 815-820.

Zuckerman, A., Chastain, C. A., & Naggie, S. (2017). Retreatment options following HCV direct-acting antiviral failure. Current treatment options in infectious diseases, 9(4), 389-402.

Bagwell, A., & Chastain, C. A. (2016). Hepatitis C Treatment in HIV Coinfection: Approaches, Challenges, and Future Opportunities. Current Treatment Options in Infectious Diseases, 8(4), 379-399.

Sponsored Projects:

Koren D, Martin M, Zuckerman A, Teply R, Nabulsi N, Lee T. Expanding Hepatitis C Virus Care and Cure: National Experience Using a Clinical Pharmacist-Driven Model. Source: Gilead Science, Inc.

Zuckerman A, Gibbs K, Berger N, Nunez M, James C, Tanner SB. Impact of Pharmacist Collaborative Practice in Rheumatoid Arthritis. Source: Sanofi Inc.

Horst S, Shah N, Wolever R, Schwartz D, Beaulieu D, Dalal R, Zuckerman A. Health Coaching to Improve Medication in IBD. Source: AbbVie Inc.

Horst S, Shah N. Assessing Medication Adherence to Tofacitinib in a Real-World Practice Setting. Source: Pfizer Global Medical Grants

Podium presentations:

Chelewski R, Johnson K, Zuckerman A, DeClercq J, Choi L, Peter M, Langone A. Development of a pharmacy collaborative practice agreement to improve efficiency and management of prescribing in a renal transplant clinic. Podium presentation presented to the American Transplant Congress Annual Meeting, Boston, MA. June, 2019.

Boyle K, Edmonds C, Schlendorf K, Gray J, Lindenfeld J, Pollack A, Fowler R. Appropriate management of drug interactions results in safe use of hepatitis c therapies in heart transplant recipients. Podium presentation presented to The International Society for Heart & Lung Transplantation Annual Meeting, Orlando, FL. April, 2019.

Haydek J, Shah N, Slaughter JC, Ashton J, Zuckerman A, Wong R, Raffe F, Garrett A, Duley C, Annis K, Wagnon J, Gaines L, Dalal R, Scoville E, Beaulieu D, Schwartz D, Horst S. Risk factors for non-adherence to biologic therapy in adult patients with inflammatory bowel disease (IBD): a retrospective analysis. Podium presentation presented to the American College of Gastroenterology Annual Scientific Meeting, Philadelphia, PA. October, 2018.

Goettel A. Efficacy and Safety of Abatacept, Adalimumab, and Etanercept in Pediatric Patients with Juvenile Idiopathic Arthritis. Podium presentation at Pediatric Pharmacy Advocacy Group Annual Meeting. Oklahoma City, OK, April 2019.

Cody Chastain, Jakea Johnson, Karen Miller, Katie Moore, Amanda Lako, Autumn Zuckerman, Jin Han, Wes Self. Universal Hepatitis C Screening in a Tennessee Tertiary Care Emergency Department. Presented at ID Week, October 2018 [Gilead Sponsored, FOCUS report].

Jennifer Haydek, Nisha Shah, James Christopher Slaughter, Jonathan Ashton, Autumn Zuckerman, Rochelle Wong, Francesca Raffe, Ailish Garrett, Caroline Duley, Kim Annis, Julianne Wagnon, Lawrence Gaines, Robin Dalal, Elizabeth Scoville, Dawn Beaulieu, David Schwartz, Sara Horst. Risk Factors for Non-Adherence to Biologic Therapy in Adult Patients with Inflammatory Bowel Disease (IBD): A Retrospective Analysis. Presented at ACG 2018, October 2018.

Heather W. O’Dell, Callie R. Darragh, Sarah S. Smith, Kelly Schlendorf, Roman E. Perri, Joseph Awad, Ashish S. Shah, Cori Edmonds, Alicia Carver, Chan Y. Chung. Multispecialty Collaboration Benefits Efforts at Expanding Donor Pools: Transplanting HCV Positive Grafts into HCV Negative Heart Transplant Recipients. To be presented to AASLD The Liver Meeting, San Francisco CA, November 2018.

Poster presentations:

Moore E, Kelly S, Alexander L, Luther P, Cooper R, Rebeiro P, Zuckerman A, Hargreaves M, Bourgi K, Schlundt D, Bonnet K, Pettit A. Healthcare provider attitudes and knowledge around pre-exposure prophylaxis (PrEP) for the prevention of HIV-infection in Tennessee. Poster presented at ID Week 2019. Washington, DC. October, 2019.

Haydek J, Shah N, Zuckerman A, Wong R, Garret A, Duley C, Annis K, Wagnon J, Dalal R, Scovile E, Beaulieu D, Schwartz D, Slaughter C, Horst S. Non-adherence to Self-injectable Biologic Medication in Patients with moderate to Severe Inflammatory Bowel Disease is Associated with Increased Healthcare Resource Utilization. To be presented at Digestive Disease Week 2019. San Diego, California. May 18-21, 2019.

Ward-Isbell A, Peter M. Converting Prescriptions to 90-day Supply Increases Specialty Pharmacy Technician Efficiency. Poster presented at Pharmacy Quality Alliance Annual Meeting. Baltimore, MD. May 2019.

Crothers G, Shah N, Kim M, Zuckerman A. Development of a Quality Measures Tool for the Utilization of Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer: An Integrated Specialty Pharmacy Initiative. Poster presented at Pharmacy Quality Alliance Annual Meeting. Baltimore, MD. May 2019.

Nabulsi NA, Martin MT, Sharp LK, Koren DE, Teply R, Zuckerman A, Lee TA. Prediction Model of Treatment Failure Among Chronic Hepatitis C Patients at Four United States Institutions. ISPOR 2019. New Orleans, Louisiana, May 21, 2019.

Johnson K, Haffler Z, Miller L. Pharmacist Managed Lithium in an Inpatient Academic Medical Center. College of Psychiatric and Neurologic Pharmacists Annual Meeting, Salt Lake City, UT, April 2019

Peter M, Chakrabarti A, Gipson H, Gregory WT, DeClercq J, Choi L, Gibbs K, Tanner SB. Lapses and discontinuations in denosumab therapy: Associations with fracture incidence. Poster presented to International Society for Clinical Densitometry Annual Meeting, Kuala Lumpur, Malaysia, March 2019.

Chelewski R, Johnson K, Zuckerman A, Peter M, DeClercq J, Choi L, Langone A. Development of a Pharmacy Collaborative Practice Agreement to Improve Efficiency and Management of Prescribing in a Renal Transplant Clinic. Presented at Academy of Managed Care and Specialty Pharmacy Annual Meeting. San Diego, CA. March 2019.

Cherry E, Jolly J, Zuckerman A, Peter M. Adherence to Specialty Medications: Assessing Rates and Correlates of Nonadherence at an Integrated Specialty Pharmacy. Presented at Academy of Managed Care and Specialty Pharmacy Annual Meeting. San Diego, CA. March 2019.

Nix R, Looney B, Lamb C, Peter M, Zuckerman A. A Targeted Approach to Reducing Rates of Discontinuation and Dose Reduction in Patients Receiving Sorafenib or Regoranfenib. Presented at Academy of Managed Care and Specialty Pharmacy Annual Meeting. San Diego, CA. March 2019.

Zuckerman A, Peter M, Johnson J, Miller K, Chastain C. Referral Source Matters: The Hepatitis C Cascade of Care for Traditional versus Emergency Department Referrals. Presented at ASHP Midyear Clinical Meeting, Anaheim, CA. December 2018.

Cornell RF, Goldhaber S, Engelhardt BG, Moslehi J, Jagasia M, Patton D, Harrell S, Hall R, Wyatt H, Piazza G. Prospective Study of Apixaban for Primary Prevention of Venous Thromboembolism in Patients with Multiple Myeloma Receiving Immunomodulatory Therapy, a 3-month Interim Analysis. Presented at Annual Meeting & Exposition of the American Society of Hematology, San Diego, CA. December 2018

Berger N, Peter M, DeClerq J, Choi L, Zuckerman A. Adherence to Disease-Modifying Anti-Rheumatic Drugs in Patients in an Integrated Clinic and Specialty Pharmacy. Presented at ASHP Midyear Clinical Meeting, Anaheim, CA. December 2018.

Koren D, Zuckerman A, Teply R, Nabulsi N, Lee T, Martin MT. Expanding Hepatitis C Virus Care and Cure: National Experience Using a Clinical Pharmacist-Driven Model. Poster to be presented at The Liver Meeting. San Francisco, CA. November 2018

Paolella D, Zuckerman A, Cherry E, Jolly J. Closing the Gap: Identifying Rates and Reasons for Nonadherence in a Specialty Population. Poster Presented to AMCP Nexus 2018. Orlando, FL. October 2018. *Silver Ribbon Abstract

Wyatt H, Zuckerman A, Peter M, Starks S, Maulis M, Declerq J, Choi L, Jagasia M. Predicting Time to Medication Access for Hematologic Malignancies: The Impact of an Integrated Specialty Pharmacy and Limited Distribution Drug Networks. Poster Presented to AMCP Nexus 2018. Orlando, FL. October 2018.

Cherry E, Jolly JA, Zuckerman A. Using Rates of Non-Adherence to Identify Opportunities for Intervention in Outpatient Specialty Clinics. Poster presented to National Association of Specialty Pharmacy Annual Meeting, Washington DC. September, 2018.

Reynolds V, Peter M, Jolly J, Chinn M, Nwosu S, Choi L, Zuckerman A. Impact of an Integrated Clinical and Specialty Pharmacy Service Model on Access to PCSK9 Inhibitor Therapy (Encore). Poster presented to National Association of Specialty Pharmacy Annual Meeting, Washington DC. September 2018.

Lines T, Carver A, Zuckerman A, Chastain C. Persistent Viremia on DAA Therapy: Real-World Experience, Interventions, and Outcomes. American College of Clinical Pharmacy Updates in Therapeutics. Jacksonville, FL. February, 2018.

Chinn M, Reynolds V, Jolly J, Zuckerman A, Kelley T. Impact of an Integrated Clinical and Specialty Pharmacy Service Model on Access to PCSK9 Inhibitor Therapy. American Society of Health-Systems Pharmacists Midyear Clinical Meeting and Exhibition. Orlando, FL. December 3-7, 2017.

Singleton E, Boils B, Litten K, Burkes S, Zuckerman A. Factors That Impact Treatment Completion of Teriparatide. Poster presented at: American Society of Health-Systems Pharmacists Midyear Clinical Meeting and Exhibition. Orlando, FL. December, 2017.

Douglas A, Chastain C, Zuckerman A. Adjustments to Antiretroviral Therapy Regimens in Co-Infected Human Immunodeficiency Virus and Hepatitis C Virus Patients. American Society of Health-Systems Pharmacists Midyear Clinical Meeting and Exhibition. Orlando, FL. December, 2017.

Bagwell A, Douglas A, Farris K, Chastain C. Evaluation of the Hepatitis C Cascade of Care in a Multidisciplinary Infectious Diseases Clinic. ID Week. San Diego, CA. October, 2017.

Zuckerman A, Douglas A, Farris K, Chastain C. Merit project: optimizing the hepatitis c cascade of care in the direct-acting antiviral era. Poster presented to the American College of Clinical Pharmacy Annual Meeting, Phoenix, AZ. October, 2017.

Singleton E, Boils B, Litten K, Burkes S, Zuckerman A. Assessing the Impact of High Touch Specialty Pharmacy Services in Patients Receiving Teriparatide. National Association of Specialty Pharmacy Annual Meeting. Washington DC. September, 2017.

Carver A, Porayko M. Retreatment of Genotype 1 Hepatitis C Virus with Sofosbuvir, Simeprevir, and Ribavirin Following Treatment Failure with an NS5A-Containing Direct-Acting Antiviral Regimen. National Association of Specialty Pharmacy Annual Meeting. Washington DC. September, 2017.

Mitchell R, Shah N, Terry S, Slack S, Zuckerman A, Jolly J. Improving Medication Adherence in Pulmonary Arterial Hypertension: An Integrated Specialty Pharmacy Approach. National Association of Specialty Pharmacy Annual Meeting. Washington DC. September, 2017.

Jolly J, Markley B, Holder G, Banks A, Zuckerman S, Zuckerman A. Improving Adherence to Multiple Sclerosis Disease Modifying Therapies through an Integrated Specialty Pharmacy Model. National Association of Specialty Pharmacy Annual Meeting. Washington DC. September, 2017.

Bagwell A, Chastain C. Improvements following clinical pharmacist integration in the management of hepatitis c. Poster presented to the National Association of Specialty Pharmacy Annual Meeting, Washington, DC. September, 2017.

Beavers J, Nelsen C, Carver A, Bagwell A. Real World Assessment of Interferon Free Oral Sofosbuvir Based Therapy in Hepatitis C Patients. National Association of Specialty Pharmacy Annual Meeting. Washington DC. September, 2017.

Nelsen C, Carver A. Real World Assessment of All-Oral, Sofosbuvir-Based, Hepatitis C Therapy at an Academic Medical Center with Integrated Specialty Pharmacy Services. National Association of Specialty Pharmacy Annual Meeting. Washington DC. September, 2017.

Bagwell A, Chastain C. An interdisciplinary team approach to hepatitis c evaluation and treatment: assessing the impact of clinical pharmacist involvement on HCV clinical practice and treatment. Poster presented to the American College of Clinical Pharmacy Annual Meeting, Hollywood, FL. October, 2016.